Skip to content

Comparison of relieving post-needling soreness with repetitive peripheral magnetic stimulation (rPMS) compared with sham

Comparison of relieving post-needling soreness with repetitive peripheral magnetic stimulation (rPMS) compared with sham

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20230713013
Enrollment
40
Registered
2023-07-13
Start date
2023-06-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myofascial pain trigger point at the upper trapezius muscle myofascial pain syndrome, dry needling, acupuncture, trigger point, office syndrome, post-needling soreness, peripheral magnetic stimulation

Interventions

Standard mode Normal current direction Biphasic waveform Inter pulse interval 10msec Burst pulse 2 Pulse B/A ratio 1.0 Repetitive rate 20 pulses per seconds pulse in train 20 Total
minimal intensity that visible muscle contraction , Standard mode Normal current direction Biphasic waveform Inter pulse interval 10msec Burst pulse 2 Pulse B/A ratio 1.0 Repetitive rat
repetitive peripheral magnetic stimulation ,repetitive peripheral magnetic stimulation

Sponsors

Panyananthaphikkhu Chonprathan Medical Center Srinakharinwirot University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients with myofascial pain syndrome of the upper trapezius muscle with at least one myofascial pain trigger point treated by Deep Dry Needling Muscle and twitching were recorded using ultrasound and recorded in the form of a video clip. 2. Body mass index 19 to 25 kg/m2.

Exclusion criteria

Exclusion criteria: 1. Patients with metal magnets within the head or treatment area within 30 cm, such as sutures, clips, coils, magnetic dental implants or implanted insulin pumps. 2. Patients with digital therapeutic tools such as pacemakers, implantable cardioverter-defibrillators, vagus nerve stimulators [VNS] and wearable cardioverter-defibrillators. 3. Patients with a history of seizures or uncontrolled seizures. 4. Pregnant women 5. patients with severe or recent heart disease 6. History of treatment with repetitive peripheral magnetic stimulation (rPMS) 7. Have a history of taking painkillers anti-inflammatory drugs and muscle relaxants within 24 hours 8. Have a bleeding disorder such as haemophilia or take blood-thinning medication. (anticoagulant) 9. Has a fear of needles 10. Abnormal skin conditions at the acupuncture site, such as rashes, dermatitis, or infection 11. Allergies to disinfectants used to clean the skin, such as alcohol or povidone-iodine. 12. Allergic to needles or metal 13. Allergic to adhesive plaster or Tegaderm

Design outcomes

Primary

MeasureTime frame
pain pressure threshold Immediately after completed of the intervention Commander Algometer

Secondary

MeasureTime frame
Numeric rating scale 48 hours after completed intervention pain score

Countries

Thailand

Contacts

Public Contactchomkajee sukareechai

Panyananthaphikkhu Chonprathan Medical Center Srinakharinwirot University

chomkajee@gmail.com0818038182

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026